IncFact
Company Profiles: Revenue, Growth, Competition

HALOZYME THERAPEUTICS Revenue, Growth & Competitor Profile

DBA HALOZYME, INC.
Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Halozyme Therapeutics

Access the complete profile.

Halozyme Therapeutics Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes42421
Address12390 El Camino Real
San Diego, CA 92130

halozyme.com


Halozyme Therapeutics's annual revenues are $100-$500 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Scientific Research & Development Services industry.


Halozyme Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Halozyme Therapeutics is a publicly traded company on NMS using the ticker symbol HALO. Detailed information on company financials and operating reports can be found here: NMS: HALO



Halozyme Therapeutics Annual Revenue and Growth Rate

Halozyme Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Halozyme Therapeutics's revenues are gauged from an analysis of company filings.



Trademark Applications

Trademark applications show the products and services that Halozyme Therapeutics is developing and marketing. Halozyme Therapeutics doesn't have any recent trademark applications, indicating Halozyme Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
VORHADIA
Pharmaceutical preparations for cancer treatments
10/04/2018
DEGRYHA
Pharmaceutical preparations for cancer treatment
10/04/2018
PERHAZO
Pharmaceutical preparations for cancer treatment
10/04/2017

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Halozyme Therapeutics grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Halozyme Therapeutics is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Scientific Research & Development Services

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Halozyme Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Halozyme Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSReston, VA100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM31 
INC RESEARCHRaleigh, NC28 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
ILLUMINASan Diego, CA13 
UT-BATTELLEOak Ridge, TN12 
PRA HOLDINGSRaleigh, NC12 
BATTELLE ENERGY ALLIANCEIdaho Falls, ID11 




Nearby Competitors

These companies are similar in business line and location to Halozyme Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ILLUMINASan Diego, CA100 
NEUROCRINE BIOSCIENCESSan Diego, CA23 
SANTARUSSan Diego, CA16 
HALOZYME THERAPEUTICSSan Diego, CA15 
MIRATI THERAPEUTICSSan Diego, CA12 
FATE THERAPEUTICSSan Diego, CA11 




Future Competition: Halozyme Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Halozyme Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Halozyme Therapeutics Competitors